Abstract | BACKGROUND/AIMS: METHODOLOGY: We analyzed 197 CRC patients with elevated PreCA19-9 (>=37U/mL). Serum levels of CEA and CA19-9 were monitored postoperatively, according to standard protocol. IndexCEA and IndexCA19-9 were defined as the levels of CEA and CA19-9, respectively, recorded at recurrence confirmation or at the last follow-up of non-recurrence. RESULTS: There were 56 recurrences during follow-up. IndexCA19-9 (cut-off, 38.6U/mL) had better sensitivity (0.80 vs. 0.68) and specificity (0.87 vs. 0.83) than did IndexCEA (cut-off. 2.8ng/mL). Area under the curve (AUC) analysis revealed that although IndexCA19-9 (0.90; 95% confidence interval [CI], 0.84-0.95) had better coverage than IndexCEA (0.84; 95% CI, 0.78-0.90), there was no significant difference (p=0.085). With the progressive rising of PreCA19-9 levels, we observed the trend of better AUC performance of IndexCA19-9 over IndexCEA. At a cut-off of 42U/mL for PreCA19-9, IndexCA19-9 began to have significantly better coverage than IndexCEA (p=0.027). CONCLUSION: The surveillance advantage of CA19-9 over CEA was shown in the group of patients with preoperative CA19-9 levels >42U/mL.
|
Authors | Shung-Haur Yang, Jeng-Kai Jiang, Shih-Ching Chang, Chi-Jung Juang, Jen-Kou Lin |
Journal | Hepato-gastroenterology
(Hepatogastroenterology)
2013 Jul-Aug
Vol. 60
Issue 125
Pg. 1021-7
ISSN: 0172-6390 [Print] Greece |
PMID | 23321120
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CA-19-9 Antigen
- Carcinoembryonic Antigen
|
Topics |
- Adult
- Aged
- Area Under Curve
- CA-19-9 Antigen
(blood)
- Carcinoembryonic Antigen
(blood)
- Colorectal Neoplasms
(blood)
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
|